Related Experiment Video

Updated: Mar 30, 2026

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
10:41

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues

Published on: April 5, 2018

11.0K

Identification of the specific epigenetic alterations associated with chemo-resistance via reprogramming of cancer

Jong Joo Kim1, Rajani Rai1

  • 1School of Biotechnology, Yeungnam University, Gyeongsan, Gyeongbuk 712-749, South Korea.

Medical Hypotheses
|November 4, 2015
PubMed
Abstract

Insights

Cellular reprogramming can create homogenous cancer cell colonies, aiding the identification of specific epigenetic changes driving chemo-resistance. This approach offers new therapeutic strategies for overcoming drug resistance in cancer treatment.

Area of Science:

  • Cancer Research
  • Epigenetics
  • Cellular Biology

Background:

  • Chemo-resistance is a major challenge in cancer therapy, often driven by epigenetic modifications.
  • Epigenetic changes are reversible, offering a potential therapeutic target.
  • Tumor cell heterogeneity complicates the identification of specific epigenetic drivers of chemo-resistance.

Purpose of the Study:

  • To overcome cancer cell heterogeneity by generating homogenous colonies through reprogramming.
  • To identify precise epigenetic alterations underlying specific chemo-resistance.
  • To explore novel therapeutic avenues for cancer treatment.

Main Methods:

  • Cancer cells undergo cellular reprogramming to generate homogenous colonies.
  • Homogenous colonies are subjected to lineage specification and long-term drug treatment.
  • Drug-resistant cells are compared to parent and reprogrammed cells for whole-genome epigenetic signatures.

Main Results:

  • Cellular reprogramming successfully generated homogenous cancer cell colonies.
  • Comparison revealed specific epigenetic signatures associated with chemo-resistance.
  • This method allows for the precise identification of epigenetic aberrations contributing to drug resistance.

Conclusions:

  • Cellular reprogramming is a viable strategy to address cancer cell heterogeneity.
  • Identifying specific epigenetic modulations linked to drug resistance opens new research avenues.
  • This approach holds promise for developing targeted cancer therapies to overcome chemo-resistance.
Keywords:
CancerCellular reprogrammingDrug resistanceEpigeneticHeterogeneity

More Related Videos

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

3.7K
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.6K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
4.2K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.3K
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.4K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.4K